BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 22396492)

  • 1. Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
    Giulianelli S; Vaqué JP; Soldati R; Wargon V; Vanzulli SI; Martins R; Zeitlin E; Molinolo AA; Helguero LA; Lamb CA; Gutkind JS; Lanari C
    Cancer Res; 2012 May; 72(9):2416-27. PubMed ID: 22396492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins].
    Giulianelli S; Vaqué JP; Wargon V; Soldati R; Vanzulli SI; Martins R; Zeitlin E; Helguero L; Lamb C; Molinolo AA; Gutkind JS; Lanari C
    Medicina (B Aires); 2012; 72(4):315-20. PubMed ID: 22892083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
    Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
    Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequences.
    Giulianelli S; Riggio M; Guillardoy T; Pérez Piñero C; Gorostiaga MA; Sequeira G; Pataccini G; Abascal MF; Toledo MF; Jacobsen BM; Guerreiro AC; Barros A; Novaro V; Monteiro FL; Amado F; Gass H; Abba M; Helguero LA; Lanari C
    Int J Cancer; 2019 Oct; 145(7):1874-1888. PubMed ID: 30843188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation.
    Salatino M; Beguelin W; Peters MG; Carnevale R; Proietti CJ; Galigniana MD; Vedoy CG; Schillaci R; Charreau EH; Sogayar MC; Elizalde PV
    Oncogene; 2006 Dec; 25(59):7723-39. PubMed ID: 16799639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer.
    Cerliani JP; Guillardoy T; Giulianelli S; Vaque JP; Gutkind JS; Vanzulli SI; Martins R; Zeitlin E; Lamb CA; Lanari C
    Cancer Res; 2011 May; 71(10):3720-31. PubMed ID: 21464042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.
    Wargon V; Riggio M; Giulianelli S; Sequeira GR; Rojas P; May M; Polo ML; Gorostiaga MA; Jacobsen B; Molinolo A; Novaro V; Lanari C
    Int J Cancer; 2015 Jun; 136(11):2680-92. PubMed ID: 25363551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha.
    Perkins MS; Louw-du Toit R; Jackson H; Simons M; Africander D
    Front Endocrinol (Lausanne); 2022; 13():959396. PubMed ID: 36187129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.
    Chen FP; Chien MH; Chen HY; Huang TS; Ng YT
    Taiwan J Obstet Gynecol; 2013 Sep; 52(3):365-73. PubMed ID: 24075375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor.
    McGowan EM; Russell AJ; Boonyaratanakornkit V; Saunders DN; Lehrbach GM; Sergio CM; Musgrove EA; Edwards DP; Sutherland RL
    Cancer Res; 2007 Sep; 67(18):8942-51. PubMed ID: 17875737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.
    Eeckhoute J; Carroll JS; Geistlinger TR; Torres-Arzayus MI; Brown M
    Genes Dev; 2006 Sep; 20(18):2513-26. PubMed ID: 16980581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Qiu C; Shan L; Yu M; Snyderwine EG
    Carcinogenesis; 2005 Apr; 26(4):763-9. PubMed ID: 15637090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y; Wu J; Stancel GM; Hyder SM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.
    Izzo F; Mercogliano F; Venturutti L; Tkach M; Inurrigarro G; Schillaci R; Cerchietti L; Elizalde PV; Proietti CJ
    Breast Cancer Res; 2014 Dec; 16(6):491. PubMed ID: 25479686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.
    Karmakar S; Gao T; Pace MC; Oesterreich S; Smith CL
    Mol Endocrinol; 2010 Jun; 24(6):1187-202. PubMed ID: 20392877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells.
    Castoria G; Giovannelli P; Lombardi M; De Rosa C; Giraldi T; de Falco A; Barone MV; Abbondanza C; Migliaccio A; Auricchio F
    Oncogene; 2012 Nov; 31(46):4868-77. PubMed ID: 22266855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH; Rowan BG
    Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells.
    Labriola L; Salatino M; Proietti CJ; Pecci A; Coso OA; Kornblihtt AR; Charreau EH; Elizalde PV
    Mol Cell Biol; 2003 Feb; 23(3):1095-111. PubMed ID: 12529413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity.
    Wang C; Fan S; Li Z; Fu M; Rao M; Ma Y; Lisanti MP; Albanese C; Katzenellenbogen BS; Kushner PJ; Weber B; Rosen EM; Pestell RG
    Cancer Res; 2005 Aug; 65(15):6557-67. PubMed ID: 16061635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.
    Diep CH; Ahrendt H; Lange CA
    Steroids; 2016 Oct; 114():48-58. PubMed ID: 27641443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.